Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-330
Closed -$12K 6661
2019
Q2
$12K Sell
330
-132
-29% -$4.51K ﹤0.01% 6513
2019
Q1
$14K Sell
462
-11,550
-96% -$353K ﹤0.01% 6460
2018
Q4
$333K Buy
+12,012
New +$330K ﹤0.01% 4186

Other funds holding ACA

Barclays's ACA Position: Q2 2026 in Review

Barclays reduced its Arcosa (ACA) stake by 19% in Q2 2026, selling an estimated $359K and leaving 12,336 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2411.

Barclays first reported a position in ACA in Q4 2018 and has held it in 31 quarters since. The position peaked at $11.4M in Q4 2025. 428 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

  • Barclays held 12,336 shares of Arcosa worth $1.79M as of Q2 2026.
  • Barclays sold 2,887 Arcosa shares in Q2 2026, an estimated $359K.
  • Arcosa made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2411 holding.
  • Barclays first reported a position in Arcosa in Q4 2018 and has held it in 31 quarters since.
  • Barclays's Arcosa position peaked at $11.4M in Q4 2025.
  • 428 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.